CN102764421B - Pressure ulcer ointment - Google Patents
Pressure ulcer ointment Download PDFInfo
- Publication number
- CN102764421B CN102764421B CN201210283350.4A CN201210283350A CN102764421B CN 102764421 B CN102764421 B CN 102764421B CN 201210283350 A CN201210283350 A CN 201210283350A CN 102764421 B CN102764421 B CN 102764421B
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- pressure ulcer
- rhizoma
- ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 39
- 239000002674 ointment Substances 0.000 title claims abstract description 29
- 206010011985 Decubitus ulcer Diseases 0.000 title abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241001446509 Psoralea Species 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 abstract description 15
- 231100000397 ulcer Toxicity 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 8
- 241000219100 Rhamnaceae Species 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000207783 Ipomoea Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 6
- 230000003387 muscular Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 241000759264 Rhamnus crenata Species 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicine, in particular to a pressure ulcer ointment. The ointment comprises, by weight, 40 parts of roots of oriental buckthorn, 1 part of tall gastrodia tuber, 30 parts of calamine, 5 parts of ginger, 16 parts of frankincense, 20 parts of acorus gramineus, 5 parts of malaytea scurfpea fruit and 5 parts of pharbitis seeds. The pressure ulcer ointment has good effects on ulcer curing and promotion of tissue regeneration, can take effect after two-day use, the used medicine types are few, the preparation is simple, the ointment is convenient to use, the effective rate can reach 100%, and the ointment is the first choice for pressure ulcer patients.
Description
technical field
The present invention relates to Chinese medicine technical field, particularly a kind of band bed sore ointment.
background technology
(the national pressure ulcer advisory panel of American National pressure ulcer advisor group, NPUAP) to the definition of pressure ulcer, be " pressure ulcer is to be confined to skin or hypodermic infringement; be often positioned at skeleton protruding part, relevant with pressure, friction and (or) shearing force ".Because most of pressure ulcer is preventible, so domestic, have health organ by it index as medical and nursing quality height, in management review standard, requiring situation of all-level hospitals patient's the number that occurs in pressure ulcer year is zero, but reality seldom has hospital can reach this standard.Because in specific crowd, pressure ulcer has the necessity of its generation, and treatment difficulty.The statistical data demonstration of the U.S. in 2004, the patient of concurrent pressure ulcer accounts for 14%～17% of inpatient, and the sickness rate of European inpatient pressure ulcer accounts for 18.1% of inpatient.Pressure ulcer not only brings misery to patient, also affects the recovery of primary disease, extends the hospital stays, increases hospitalization cost, even causes health to worsen or death.Pressure ulcer is the common difficulty that world health health institution faces.
Decubital ulcer, claims again pressure ulcer, bed-sore, pressure ulcer, is due to the long-term pressurized of local organization, and skin is for hypoxgia, generation continuous ischemia, anoxia, the necrosis of malnutrition Er Zhi tissue fester.Skin decubital ulcer is the problem of a universality in rehabilitation, nursing.At present clinical treatment is mainly that anti-inflammation is main, prevents secondary infection, but regeneration does not have good way for muscular tissue, because the granulation promoting open sore part that heals rapidly, so clinical efficacy is unsatisfactory.
Also have on the market now a lot of special ointment for pressure ulcer, its composition is mostly that therapeutic effect is not very satisfactory with medical materials such as the Radix Astragali, Fructus Forsythiae, Radix Angelicae Sinensis, the Radixs Angelicae Dahuricae.
summary of the invention
In order solving in above prior art, to treat the undesirable problem of decubital ulcer effect, to the invention provides a kind of effective band bed sore ointment of decubital ulcer for the treatment of.
The present invention is achieved by the following measures:
A band bed sore ointment, crude drug weight proportion is as follows:
40 parts of Radix rhamni crenataes, 1 part, Rhizoma Gastrodiae, 30 parts of Calamina (calcined and quenched), 5 parts, Rhizoma Zingiberis Recens, 16 parts of Olibanums, 20 parts of Rhizoma Acori Graminei, 5 parts of Fructus Psoraleaes, 5 parts of Semen Pharbitidiss;
Described band bed sore ointment obtains by following steps:
(1) weighting raw materials, Radix rhamni crenatae, Rhizoma Gastrodiae, Rhizoma Zingiberis Recens, Olibanum, Rhizoma Acori Graminei, Fructus Psoraleae and Semen Pharbitidis are mixed, the water that adds 10 times of weight, decoct 2-3 hour, filtering residue adds the water of 5 times of weight again, decocts 1-2 hour, merging filtrate, being concentrated into 50 ℃ of relative densities is 1.2-1.3, obtains concentrated solution;
(2) Calamina (calcined and quenched) is crushed to 100 orders, adds in concentrated solution, stir, obtain.
Radix rhamni crenatae: Radix rhamni crenatae is root or the root bark of Rhamnaceae plant rhamnus crenata sieb.et zucc..There is the effect of clearing away heat-damp and promoting diuresis, parasite killing, removing toxic substances.
Rhizoma Gastrodiae: endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Calamina (calcined and quenched): Calamina (calcined and quenched).
Rhizoma Zingiberis Recens: relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, warming the lung to relieve cough, solving toxin of fish and crab, separates poison of drug.
Olibanum: regulating qi and activating blood, analgesic therapy, chases after poison.
Rhizoma Acori Graminei: can dirtyly have one's ideas straightened out for warding off, a surname's gas is by expectorant, removing toxic substances, parasite killing.
Fructus Psoraleae: reinforcing the kidney and supporting YANG; Helping inspiration to relieve asthma; Warming spleen and stopping diarrha.
Semen Pharbitidis: removing water retention by purgation relieving constipation, drink is washed in expectorant, and parasite killing is attacked long-pending.
Beneficial effect of the present invention: band bed sore ointment of the present invention, expelling pus and promoting granulation is effective, and instant effect is used and just takes effect for 2 days, uses medicament categories few, and preparation is simple, and easy to use, effective, effective percentage reaches 100%, is the first-selection of vast patients with bedsore.
The specific embodiment
For a better understanding of the present invention, below in conjunction with specific embodiment, further illustrate.
A band bed sore ointment, crude drug weight proportion is as follows:
40 parts of Radix rhamni crenataes, 1 part, Rhizoma Gastrodiae, 30 parts of Calamina (calcined and quenched), 5 parts, Rhizoma Zingiberis Recens, 16 parts of Olibanums, 20 parts of Rhizoma Acori Graminei, 5 parts of Fructus Psoraleaes, 5 parts of Semen Pharbitidiss;
Described band bed sore ointment obtains by following steps:
(1) weighting raw materials, Radix rhamni crenatae, Rhizoma Gastrodiae, Rhizoma Zingiberis Recens, Olibanum, Rhizoma Acori Graminei, Fructus Psoraleae and Semen Pharbitidis are mixed, the water that adds 10 times of weight, decoct 2-3 hour, filtering residue adds the water of 5 times of weight again, decocts 1-2 hour, merging filtrate, being concentrated into 50 ℃ of relative densities is 1.2-1.3, obtains concentrated solution;
(2) Calamina (calcined and quenched) is crushed to 100 orders, adds in concentrated solution, stir, obtain.
Using method: band bed sore ointment is smeared in bedsore wound, smeared 50g ointment for every square centimeter, change dressings once every day.
clinical effectiveness checking
Choose patients with bedsore 50 examples, 122 of total decubital ulcers, fill in questionnaire by special messenger, and detailed medical history-taking, through health check-up comprehensively, all without complication such as septicemia.
According to patient's decubital ulcer by stages and the order of severity mark, be divided into two groups, treatment group and matched group, the decubital ulcer overall score result no difference of science of statistics of selected two groups.
Therapeutic Method:
1, treatment group: treat according to the band bed sore ointment using method of the present invention of embodiment 1, according to a course for the treatment of of first quarter moon, treat, until recovery from illness.
2, matched group: according to traditional Therapeutic Method iodophor disinfection, heat lamp is roasting, and dry the drying in the air of the open sore part will not be wrapped up, transfusion and supporting treatment.
All cases is observed two months, and result is as following table.
| Group | Decubital ulcer quantity | Cure quantity | Effective quantity | Effective quantity | Invalid quantity | Total effective rate |
| Treatment group | 61 | 44 | 16 | 1 | 0 | 100﹪ |
| Matched group | 61 | 25 | 17 | 7 | 12 | 80﹪ |
Conclusion: experiment shows, the therapeutic outcome of two groups has more significant difference, cure rate particularly, this band bed sore ointment reaches 72 ﹪, and the cure rate of matched group only has 41 ﹪, the total effective rate of decubital ulcer of the present invention reaches 100%, and matched group only has 80%, illustrate that band bed sore ointment of the present invention is greatly improved than traditional remedies in curative effect, has good therapeutic effect clinically.The patient who uses ointment of the present invention, without any untoward reaction, illustrates without any side effects.
typical treatment case
(1) history, 78 years old, female, patient is because of hypertension, cerebral infarction, is paralyzed in bed for a long time, because skin is oppressed for a long time, skin can not get the normal keeping of blood, has occurred the serious decubital ulcer of 9.2 centimetres of diameters at patient's buttocks, sacrococcyx, deeply reaches the underlying soft tissue of muscle.Repeatedly seek medical advice and have no result, ten thousand parts of the hope of healing are remote, use band bed sore ointment treatment of the present invention, 50 grams of ointment of the present invention of every square centimeter of use of wound are smeared on wound, with gauze, wrap up, and change medicine every day one time, in medication second day, just find that dry incrustation Convergent Phenomenon appears in decubital ulcer surface, after one course for the treatment of of medication, find to occur new muscular tissue at wound surface, through 47 days, give meticulous treatment, the thorough rehabilitation of patient, patient skin does not leave any sequela, rear respond well.
(2) Wang, 64 years old, female, patient, because of fracture, is paralyzed in bed, and at sacrococcyx place, causes more serious decubital ulcer, and the degree of depth reaches periosteum.Use band bed sore ointment of the present invention to smear on wound, gauze is wrapped up, and changes medicine every day one time, at the 3rd day that uses ointment, finds that decubital ulcer slough has 1/3 self falling, and can observe the slough director that comes off and gone out the granulation of needle point size; Slough the 5th day decubitus wound all comes off, and can observe the muscular tissue with Semen phaseoli radiati size; After ten days, on the periosteum of the bottom of the wound of decubital ulcer, found the five new muscular tissues in place, Yi Bian the muscular tissue of growing, Yi Bian seal gradually from the surrounding of decubitus wound, in the time for the treatment of in 55 days, be almost recovered, blood capillary is high-visible, and the pain on skin feels that nerve also recovers normal.
(3) summer, 48 years old, man, patient is because traffic accident is because playing high paraplegia, and due to the long-term pressurized of buttocks, there is a wound in buttocks, and Semen Glycines is size equally, and there is the sinus tract that can hold an egg wound the inside, and approximately diameter is in 5.2cm left and right.Use band bed sore ointment of the present invention, smear on elongated meche, then putting in wound with the meche of ointment, wrapping, changes medicine every day one time, gives meticulous treatment the thorough rehabilitation of patient through 18 days, do not leave any cicatrix, and skin is as usual.
Claims (1)
1. a band bed sore ointment, is characterized in that crude drug weight proportion is as follows:
40 parts of Radix rhamni crenataes, 1 part, Rhizoma Gastrodiae, 30 parts of Calamina (calcined and quenched), 5 parts, Rhizoma Zingiberis Recens, 16 parts of Olibanums, 20 parts of Rhizoma Acori Graminei, 5 parts of Fructus Psoraleaes, 5 parts of Semen Pharbitidiss;
Described band bed sore ointment obtains by following steps:
(1) weighting raw materials, Radix rhamni crenatae, Rhizoma Gastrodiae, Rhizoma Zingiberis Recens, Olibanum, Rhizoma Acori Graminei, Fructus Psoraleae and Semen Pharbitidis are mixed, the water that adds 10 times of weight, decoct 2-3 hour, filtering residue adds the water of 5 times of weight again, decocts 1-2 hour, merging filtrate, being concentrated into 50 ℃ of relative densities is 1.2-1.3, obtains concentrated solution;
(2) Calamina (calcined and quenched) is crushed to 100 orders, adds in concentrated solution, stir, obtain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210283350.4A CN102764421B (en) | 2012-08-10 | 2012-08-10 | Pressure ulcer ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210283350.4A CN102764421B (en) | 2012-08-10 | 2012-08-10 | Pressure ulcer ointment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102764421A CN102764421A (en) | 2012-11-07 |
| CN102764421B true CN102764421B (en) | 2014-03-26 |
Family
ID=47092148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210283350.4A Expired - Fee Related CN102764421B (en) | 2012-08-10 | 2012-08-10 | Pressure ulcer ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102764421B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103142718B (en) * | 2013-03-11 | 2014-11-12 | 刘玉祥 | Liquid medicine for treating freezing injury |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188673B (en) * | 2010-03-17 | 2012-07-25 | 赵贵凤 | Plaster for promoting muscles and bones, and preparation and application thereof |
| CN102188567B (en) * | 2011-05-11 | 2012-09-12 | 张凤清 | Ointment for treating bedsore and preparation method thereof |
| CN102423479B (en) * | 2011-12-21 | 2013-04-10 | 葛爱学 | Externally applied Chinese medicinal ointment for treating bedsores and its preparation method |
-
2012
- 2012-08-10 CN CN201210283350.4A patent/CN102764421B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102764421A (en) | 2012-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091309B (en) | Pharmaceutical composition for treating bedsore and preparation method thereof | |
| CN102302661A (en) | Chinese medicinal composition for treating skin diseases | |
| CN100574783C (en) | an anti-inflammatory analgesic drug | |
| CN102940865A (en) | Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof | |
| CN102764421B (en) | Pressure ulcer ointment | |
| CN103041192B (en) | Bedsore paste | |
| CN102423479B (en) | Externally applied Chinese medicinal ointment for treating bedsores and its preparation method | |
| CN101336990B (en) | Medicine for treating cholecystitis | |
| CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
| CN101011511A (en) | Externally applied medicament for treating soft tissue injury | |
| CN105255676A (en) | Boxthorn wine and preparation method and applications thereof | |
| CN104940547A (en) | Traditional Chinese medicine combination for treating hemorrhoid and preparation technology therefor | |
| CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
| CN102274362B (en) | Plaster for treating mastopathy and preparation method thereof | |
| CN102114199B (en) | Traditional Chinese medicine for treating bone cancer | |
| CN102670839B (en) | External traditional Chinese medicine composition for treating hyperosteogeny | |
| CN103071050A (en) | Traditional Chinese medicine ointment for burns | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN102293902B (en) | Black factice for treating snake bite | |
| CN101983645A (en) | Medicament for treating acute appendicitis | |
| CN108310163A (en) | A kind of dispelling wind-evil and wetness-evil blood-activating Chinese medicine preparation and preparation method thereof | |
| CN105582223A (en) | External traditional Chinese medicine for treating acute and chronic traumatic injuries | |
| CN101810760A (en) | Black factice for treating snake bites | |
| CN101785832B (en) | Chinese medicinal preparation for treating skin diseases and preparation method thereof | |
| CN1772111A (en) | Medicinal wine for treating rheumatism and rheumatoid disease and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YUAN YONGCHUN Free format text: FORMER OWNER: WANG XUANXUAN Effective date: 20140214 |
|
| CB03 | Change of inventor or designer information |
Inventor after: Yuan Yongchun Inventor after: Wang Yuhong Inventor after: Song Chengai Inventor after: Jiang Guiling Inventor before: Wang Xuanxuan |
|
| CB03 | Change of inventor or designer information | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XUANXUAN TO: YUAN YONGCHUN WANG YUHONG SONG CHENGAI JIANG GUILING Free format text: CORRECT: ADDRESS; FROM: 250014 JINAN, SHANDONG PROVINCE TO: 266200 QINGDAO, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20140214 Address after: No. 1281 Hospital of traditional Chinese medicine in Shandong province Jimo City, Shandong province Jimo City Lan Ao Lu 266200 Applicant after: Yuan Yongchun Address before: 250014 A611, No. ten, No. 14717, Lixia District, Shandong, Ji'nan Applicant before: Wang Xuanxuan |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD. Free format text: FORMER OWNER: YUAN YONGCHUN Effective date: 20141210 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266200 QINGDAO, SHANDONG PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141210 Address after: 226100, 999, Guangzhou Road, Haimen, Jiangsu, Nantong Patentee after: Haimen Jianghai Construction Investment Co.,Ltd. Address before: No. 1281 Hospital of traditional Chinese medicine in Shandong province Jimo City, Shandong province Jimo City Lan Ao Lu 266200 Patentee before: Yuan Yongchun |
|
| CI01 | Publication of corrected invention patent application |
Correction item: transfer of the patent application right or patent right Correct: Revocation of patent transfer False: Patent transfer Number: 53 Volume: 30 |
|
| ERR | Gazette correction | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 |